EPISODE · Jul 24, 2026 · 4 MIN
今天3分钟我们来聊聊国内首个干细胞治疗卵巢早衰首例显效
from 源于细胞BioInsid的个人播客
国内首个获批的脐带间充质干细胞治疗卵巢早衰临床试验首例受试者显效，38岁罗女士输注后卵泡重新发育、激素水平改善。该疗法有望从根本修复卵巢功能，较传统激素替代治疗更具优势，为卵巢早衰患者带来新希望。 参考文献： 华中科技大学附属同济医院. 全国首例脐带间充质干细胞注射液治疗卵巢早衰临床研究（罗女士病例）. 2026. Wang S, Li Y, et al. Human umbilical cord mesenchymal stem cells protect residual ovarian function by repairing the ovarian microenvironment. Nature Aging. (团队相关成果) 国家药品监督管理局. 脐带间充质干细胞注射液治疗卵巢早衰临床试验批准. (国内首个该适应症获批临床试验) 国家妇产疾病临床医学研究中心（同济医院）统筹推进该项临床试验. 前往小宇宙评论区与主播互动
Embed this episode
Ready to play
今天3分钟我们来聊聊国内首个干细胞治疗卵巢早衰首例显效
0:00
4:03
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 源于细胞BioInsid的个人播客?
This episode is 4 minutes long.
When was this 源于细胞BioInsid的个人播客 episode published?
This episode was published on July 24, 2026.
Can I download this 源于细胞BioInsid的个人播客 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!